Last reviewed · How we verify
Nebcin
At a glance
| Generic name | Nebcin |
|---|---|
| Sponsor | University Hospital, Lille |
| Target | Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B) |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | discontinued |
Approved indications
- Allergic conjunctivitis
- Anterior uveitis
- Bacterial conjunctivitis
- Bacterial infection due to Klebsiella pneumoniae
- Bacterial infection due to Serratia
- Bacterial meningitis
- Bacterial peritonitis
- Bacterial septicemia
- Bacterial urinary infection
- Blepharoconjunctivitis
- Citrobacter Complicated UTI
- Complicated Proteus UTI
- Complicated UTI with Pseudomonas Aeruginosa
- Complicated Urinary Tract Infections
- Corneal abrasion
- Dacryocystitis
- E. Coli Osteomyelitis
- E. Coli Peritonitis
- Enterobacter Osteomyelitis
- Enterobacter Pneumonia
Common side effects
Key clinical trials
- Protocol for Expanded Access to Cyclic Irrigation of Vancomycin Hydrochloride and Tobramycin Sulfate in Patients Undergoing Exchange Arthroplasty for Periprosthetic Joint Infection of the Hip or Knee (N/A)
- Swiss PACK-CXL (Photoactivated Chromophore for Infectious Keratitis Cross-linking) Multicenter Trial for the Treatment of Infectious Keratitis (Phase 3)
- Intestinal Microbiota: a New Target for Chalaziosis Treatment in Children (NA)
- Effect of Various Treatment Modalities on Dendritic Vial Ulcer (N/A)
- Prospective Study Investigating Antibiotic Elution From Free Intra-articular Vancomycin and Tobramycin After Cementless Total Knee Arthroplasty (Phase 4)
- A Phase II Multicenter Randomized Trial of Tobramycin for Inhalation in Young Children With Cystic Fibrosis (Phase 2)
- A Multi-Center, Randomized, Double Masked, Bioequivalence Study of Tobramycin and Prednisolone Acetate (0.3/1.0%, ISTA) Ophthalmic Suspension Compared to PredForte (1.0% Prednisolone Acetate, Allergan (Phase 3)
- Long-term Inhaled Nebulized Tobramycin in Patients With Non-cystic Fibrosis Bronchiectasis. A Randomized Placebo Controlled Trial. The BATTLE Study Bronchiectasis And Tobramycin SoluTion InhaLation Th (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nebcin CI brief — competitive landscape report
- Nebcin updates RSS · CI watch RSS
- University Hospital, Lille portfolio CI